230
Participants
Start Date
June 1, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
November 30, 2024
Esketamine
Intravenous administration of a subanesthetic dose of esketamine (0.25 mg/kg) during induction of general anesthesia. The drug was administered slowly over approximately 30 seconds after midazolam (2 mg) and sufentanil (50 µg), and prior to propofol (2 mg/kg) and rocuronium (0.6 mg/kg). The goal was to evaluate its effect on intraoperative hemodynamic stability and postoperative recovery in elderly patients undergoing thoracic surgery.
Normal Saline (0.9% Sodium Chloride)
Intravenous administration of an equivalent volume of 0.9% normal saline during anesthesia induction, matching the timing and method of the esketamine group. Used as a placebo comparator.
Midazolam
Intravenous administration of 2 mg midazolam during anesthesia induction for sedation. Administered prior to study drug.
Sufentanil
Intravenous administration of 50 µg sufentanil for analgesia during anesthesia induction. Administered prior to study drug.
propofol
Intravenous administration of 2 mg/kg propofol for loss of consciousness during anesthesia induction. Administered after study drug.
Rocuronium
Intravenous administration of 0.6 mg/kg rocuronium to facilitate neuromuscular blockade and endotracheal intubation.
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Hebei Medical University Fourth Hospital
OTHER